PMID: 11605785Oct 19, 2001Paper

Ifosfamide nephrotoxicity in pediatric cancer patients

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
B S LeeY Choi

Abstract

The renal functions in pediatric cancer patients who received ifosfamide (IFO) treatment were evaluated and the risk factors related to IFO nephrotoxicity were determined. The medical records of all children treated with IFO were reviewed, and 62 with normal renal function before IFO treatment were selected. Nephrotoxicity was diagnosed by measuring urine beta2-microglobulin and glucose, and serum phosphate, bicarbonate, and creatinine. Forty-eight (77.4%) had a history of previous cisplatin treatment. Nephrotoxicity was detected in 20 patients (32.3%). beta2-Microglobulinuria was observed in all 20, hypophosphatemia in 10 (16.1%), hypocarbia in 2 (3.2%), glucosuria in 5 (8.1%), and decreased creatinine clearance in 7 (11.3%). The cumulative dose of IFO and a history of previous cisplatin therapy were related to nephrotoxicity. Among the 20 patients with nephrotoxicity, the median cumulative dose of IFO in patients with a low (<500 mg/m2) and high (>500 mg/m2) cumulative dose of previous cisplatin was 80 g/m2 (73-102 g/m2) and 45 g/m2 (11-76 g/m2), respectively. Most of the nephrotoxicity persisted after cessation of IFO treatment. In conclusion, close monitoring of IFO nephrotoxicity should be started earlier in patients with ...Continue Reading

Citations

May 15, 2002·Pharmacoepidemiology and Drug Safety
Feb 26, 2009·Current Urology Reports·Margarett ShnorhavorianMartin A Koyle
Apr 28, 1990·Lancet·P J Shaw, T Eden
Dec 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T OzakiH Jürgens
Nov 12, 2005·Journal of Pediatric Hematology/oncology·Elzbieta ZielińskaKonrad Misiura
Apr 2, 2010·QJM : Monthly Journal of the Association of Physicians·G LiamisM Elisaf
Mar 5, 2016·European Journal of Pharmacology·George LiamisMoses S Elisaf
Jan 1, 2014·Disease Markers·Małgorzata ZubowskaBeata Zalewska-Szewczyk
May 4, 2015·Bulletin du cancer·Hélène Sudour-BonnangeBernard Boudailliez
Jul 10, 2016·Pediatric Blood & Cancer·Abdullahi MudiJanet Elizabeth Poole
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Odile OberlinFlorent de Vathaire
May 10, 2005·Expert Review of Anticancer Therapy·Andrea Ferrari, Michela Casanova
Oct 9, 2013·The Cochrane Database of Systematic Reviews·Sebastiaan L KnijnenburgMonique W M Jaspers
Jul 1, 2009·Nature Reviews. Nephrology·Vaibhav SahniZiauddin Ahmed
Jun 7, 2006·Pediatric Blood & Cancer·Wolfgang StöhrRainer Rossi
Mar 12, 2019·The Cochrane Database of Systematic Reviews·Esmee Cm KooijmansMargreet A Veening
Jun 9, 2020·Frontiers in Oncology·Ignazio VerziccoAderville Cabassi
Aug 28, 2020·CA: a Cancer Journal for Clinicians·Mitchell H RosnerMark A Perazella
Dec 15, 2016·Pilot and Feasibility Studies·Jessica E MorganRobert S Phillips
Oct 1, 2013·Chemical Science·Emilia C Calvaresi, Paul J Hergenrother
Mar 4, 2014·Annals of Clinical Biochemistry·P ManghatR Swaminathan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.